Difference between revisions of "Taloporfin (Laserphyrin)"
Jump to navigation
Jump to search
(Created page with "Photosensitizer ==Diseases for which it is used== *Esophageal cancer ==History of changes in PMDA indication== *2015-05-26: new additional indication for the treatment of...") |
|||
| Line 4: | Line 4: | ||
*[[Esophageal cancer]] | *[[Esophageal cancer]] | ||
==History of changes in PMDA indication== | ==History of changes in PMDA indication== | ||
| + | *2013-09-20: new additional indication and a new dosage for the treatment of [[:Category:CNS cancers|primary malignant brain tumor]] (only for the case where surgical excision of tumor is performed). | ||
*2015-05-26: new additional indication for the treatment of recurrent [[esophageal cancer]] associated with local persistence after chemoradiotherapy or radiotherapy. | *2015-05-26: new additional indication for the treatment of recurrent [[esophageal cancer]] associated with local persistence after chemoradiotherapy or radiotherapy. | ||
Revision as of 00:06, 10 June 2023
Photosensitizer
Diseases for which it is used
History of changes in PMDA indication
- 2013-09-20: new additional indication and a new dosage for the treatment of primary malignant brain tumor (only for the case where surgical excision of tumor is performed).
- 2015-05-26: new additional indication for the treatment of recurrent esophageal cancer associated with local persistence after chemoradiotherapy or radiotherapy.